Literature DB >> 2122128

Fetal damage due to maternal phenylketonuria: effects of dietary treatment and maternal phenylalanine concentrations around the time of conception (an interim report from the UK Phenylketonuria Register).

I Smith1, J Glossop, M Beasley.   

Abstract

In 94 infants born to women with PKU, birth weight and head circumference were inversely and linearly related to the mothers' phenylalanine concentrations close to conception; with each 200 mumols/L rise in phenylalanine concentrations, birth weight fell by 98 g and head circumference by 0.46 cm. This relationship was highly significant and appeared to be the same whether or not the mother received a low phenylalanine diet. Even in the 28 infants whose mothers conceived on a strict low phenylalanine diet, birth weights and head circumferences, corrected for sex and gestation, were a little below the population norms (3421 g and 34.7 cm compared with 3600 g and 35.2 cm respectively) although the differences were not statistically significant. Optimal fetal growth occurred only in infants whose mothers had phenylalanine concentrations close to the normal range at conception. Dietary treatment started after conception did not appear to confer any benefit.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2122128     DOI: 10.1007/bf01799520

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  8 in total

1.  Maternal phenylketonuria. Detrimental effects on embryogenesis and fetal development.

Authors:  R O Fisch; D Doeden; L L Lansky; J A Anderson
Journal:  Am J Dis Child       Date:  1969-12

2.  Successful outcome of pregnancy in a phenylketonuric woman after low-phenylalanine diet introduced before conception.

Authors:  K B Nielsen; E Wamberg; J Weber
Journal:  Lancet       Date:  1979-06-09       Impact factor: 79.321

3.  Outcome of pregnancy in a phenylketonuric mother after low phenylalanine diet introduced from the ninth week of pregnancy.

Authors:  D C Davidson; D M Isherwood; J T Ireland; P G Rae
Journal:  Eur J Pediatr       Date:  1981-09       Impact factor: 3.183

4.  Maternal phenylketonuria: comparison of two treated full term pregnancies.

Authors:  R P Soeters; R C Sengers; P W van Dongen; J M Trijbels; T K Eskes
Journal:  Eur J Pediatr       Date:  1986-08       Impact factor: 3.183

5.  New England Maternal PKU Project: prospective study of untreated and treated pregnancies and their outcomes.

Authors:  F J Rohr; L B Doherty; S E Waisbren; I V Bailey; M G Ampola; B Benacerraf; H L Levy
Journal:  J Pediatr       Date:  1987-03       Impact factor: 4.406

6.  Effects of untreated maternal phenylketonuria and hyperphenylalaninemia on the fetus.

Authors:  H L Levy; S E Waisbren
Journal:  N Engl J Med       Date:  1983-11-24       Impact factor: 91.245

7.  Timing of strict diet in relation to fetal damage in maternal phenylketonuria. An international collaborative study by the MRC/DHSS Phenylketonuria Register.

Authors:  E Drogari; I Smith; M Beasley; J K Lloyd
Journal:  Lancet       Date:  1987-10-24       Impact factor: 79.321

8.  Maternal phenylketonuria and hyperphenylalaninemia. An international survey of the outcome of untreated and treated pregnancies.

Authors:  R R Lenke; H L Levy
Journal:  N Engl J Med       Date:  1980-11-20       Impact factor: 91.245

  8 in total
  15 in total

Review 1.  Preconception care: a systematic review.

Authors:  Carol C Korenbrot; Alycia Steinberg; Catherine Bender; Sydne Newberry
Journal:  Matern Child Health J       Date:  2002-06

2.  Maternal PKU collaborative study: the effect of nutrient intake on pregnancy outcome.

Authors:  R Matalon; K Michals; C Azen; E G Friedman; R Koch; E Wenz; H Levy; F Rohr; B Rouse; L Castiglioni
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

Review 3.  Late effects of phenylketonuria.

Authors:  J H Walter
Journal:  Arch Dis Child       Date:  1995-12       Impact factor: 3.791

Review 4.  Metabolic disorders of embryogenesis.

Authors:  G K Brown
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

5.  Phenylketonuria: variable phenotypic outcomes of the R261Q mutation and maternal PKU in the offspring of a healthy homozygote.

Authors:  S Kleiman; L Vanagaite; J Bernstein; G Schwartz; N Brand; A Elitzur; S L Woo; Y Shiloh
Journal:  J Med Genet       Date:  1993-04       Impact factor: 6.318

6.  The Spectrum of PAH Mutations and Increase of Milder Forms of Phenylketonuria in Sweden During 1965-2014.

Authors:  Annika Ohlsson; Helene Bruhn; Anna Nordenström; Rolf H Zetterström; Anna Wedell; Ulrika von Döbeln
Journal:  JIMD Rep       Date:  2016-07-28

7.  Nutrition and reproductive outcome in maternal phenylketonuria.

Authors:  K Michals; P B Acosta; V Austin; L Castiglioni; F Rohr; E Wenz; C Azen
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

Review 8.  Phenylketonuria due to phenylalanine hydroxylase deficiency: an unfolding story. Medical Research Council Working Party on Phenylketonuria.

Authors: 
Journal:  BMJ       Date:  1993-01-09

9.  Psychosocial factors in maternal phenylketonuria: women's adherence to medical recommendations.

Authors:  S E Waisbren; B D Hamilton; P J St James; S Shiloh; H L Levy
Journal:  Am J Public Health       Date:  1995-12       Impact factor: 9.308

10.  Insurance coverage of special foods needed in the treatment of phenylketonuria.

Authors:  B N Millner
Journal:  Public Health Rep       Date:  1993 Jan-Feb       Impact factor: 2.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.